Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles

A Ohler and U Ravens

Institut fur Pharmakologie, Universitat-Gesamthochschule Essen, Germany.

The new antiarrhythmic compounds E-4031 (1-[2-(6-methyl-2- pyridyl)ethyl]-4-(4-methylsulfonyl- aminobenzoyl)piperidine), almokalant and tedisamil prolonged the action potential duration (APD) of human right ventricular papillary muscle. In order to investigate whether drug-channel interaction takes place during rest, regular stimulation (0.5 Hz) was interrupted by three 30-min periods of quiescence. Drug was added at the beginning of the second period of rest, the third period was interposed at equilibrium of drug action. Under predrug control conditions, the first action potential after rest was longer than with regular stimulation, steady state was reached again with a monotonic time course. With E-4031 the first action potential after 30 min of drug exposure during quiescence was similar to predrug control, but drug-induced prolongation of APD developed during further stimulation, indicating drug interaction with open channels. After the third period of quiescence, the first APD remained significantly increased compared to predrug values suggesting that E- 4031 may be trapped within the resting channel. With almokalant, however, the first APD after wash-in was already prolonged and APD increased further with regular pacing. The effect was partially reversed during the third period of rest. These findings are compatible with open-channel block or no evidence for trapping. On the other hand, tedisamil prolonged APD but did not change the monophasic time course neither when added during quiescence nor at equilibrium of drug action. It is concluded that changes in APD after quiescence indicate differences among these drugs in their interactions with channel subtypes controlling repolarization.

Volume 270, Issue 2, pp. 460-465, 08/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				U Ravens and D Dobrev Regulation of sarcoplasmic reticulum Ca2+-ATPase and phospholamban in the failing and nonfailing heart Cardiovasc Res, January 1, 2000; 45(1): 245 - 252. [Full Text] [PDF]

				S. Kaab, J. Dixon, J. Duc, D. Ashen, M. Nabauer, D. J. Beuckelmann, G. Steinbeck, D. McKinnon, and G. F. Tomaselli Molecular Basis of Transient Outward Potassium Current Downregulation in Human Heart Failure : A Decrease in Kv4.3 mRNA Correlates With a Reduction in Current Density Circulation, October 6, 1998; 98(14): 1383 - 1393. [Abstract] [Full Text] [PDF]

				K. S. Lee and E. W. Lee Ionic Mechanism of Ibutilide in Human Atrium: Evidence for a Drug-Induced Na+ Current Through a Nifedipine Inhibited Inward Channel J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 9 - 22. [Abstract] [Full Text]

				J. Toyama, K. Kamiya, J. Cheng, J.-K. Lee, R. Suzuki, and I. Kodama Vesnarinone Prolongs Action Potential Duration Without Reverse Frequency Dependence in Rabbit Ventricular Muscle by Blocking the Delayed Rectifier K+ Current Circulation, November 18, 1997; 96(10): 3696 - 3703. [Abstract] [Full Text]

				E. Patterson, B. J. Scherlag, S. Sangiah, G. L. Garrison, K. M. Couch, K. D. Berlin, and R. Lazzara Class III Electrophysiologic Actions of Imidazole-Substituted Diheterabicyclononanes in Canine Myocardium J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 155 - 162. [Abstract] [Full Text]

				M. Nemeth, A. Varro, L. Virag, O. Hala, D. Thormahlen, and J. Gyula Papp Frequency-dependent Cardiac Electrophysiologic Effects of Tedisamil: Comparison With Quinidine and Sotalol Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 273 - 284. [Abstract] [PDF]

				H. Konarzewska, G. A. Peeters, and M. C. Sanguinetti Repolarizing K+ Currents in Nonfailing Human Hearts : Similarities Between Right Septal Subendocardial and Left Subepicardial Ventricular Myocytes Circulation, September 1, 1995; 92(5): 1179 - 1187. [Abstract] [Full Text]